Variable n % Range Median
Age (years)     47-83 68.7
iPSA (ng/ml)     4.1-175.0 24.2
GS     6-9 7
Follow up (Months)     24-123 62.4
Last PSA     0.01-99.7 3.4
Ethnicity         
Asiatic 17 7.4    
White 181 79.0    
Black 18 7.9    
Mulatto 13 5.7    
Clinical Stage        
T1 89 38.9    
T2a 71 31.0    
T2b 32 14.0    
T3 37 16.2    
Neo HT        
No 123 53.7    
Yes 106 46.3    
Adj HT        
No 56 24.5    
Yes 173 75.5    
Risk Group        
Intermediate 117 51.1    
High 112 48.9    
Total 229 100.0    
iPSA: Initial PSA Value; GS: Geason Score; IR: Intermediate Risk; HR: High Risk; Neo HT: Neoadjuvant Androgen Deprivation; Adj HT: Adjuvant Androgen Deprivation
Table 1: Patients characteristics.